Optimization of LMP‐specific CTL expansion for potential adoptive immunotherapy in NPC patients-Reference-Cited by-同舟云学术

Optimization of LMP‐specific CTL expansion for potential adoptive immunotherapy in NPC patients

Published:2009-05-26 Issue:6 Volume:87 Page:481-488
ISSN:0818-9641
Container-title:Immunology & Cell Biology
language:en
Short-container-title:Immunol Cell Biol

Author:

Lutzky Viviana P¹,Davis Joanne E¹²,Crooks Pauline¹,Corban Monika¹,Smith Mark C¹,Elliott Michael¹,Morrison Leanne¹,Cross Simone¹,Tscharke David³,Panizza Benedict⁴,Coman William⁴,Bharadwaj Mandvi⁵,Moss Denis J¹

Affiliation:

1. EBV Biology Laboratory, Division of immunology, Australian Centre for Vaccine Development, The Queensland Institute of Medical Research, The Royal Brisbane Hospital Brisbane Queensland Herston Australia

2. The Cancer Immunology Research Program, The Peter MacCallum Cancer Institute Melbourne Victoria East Melbourne Australia

3. School of Biochemistry and Molecular Biology, Australia National University Canberra Australia

4. Head and Neck Clinic, The Princess Alexandra Hospital Brisbane Queensland Woolloongabba Australia

5. Immunology and Microbiology Department, University of Melbourne Melbourne Victoria Parkville Australia

Funder

Garnett Passe and Rodney Williams Memorial Foundation

Publisher

Wiley

Subject

Cell Biology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1038/icb.2009.25

Reference29 articles.

1. COMPLETE REGRESSION OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE USING PARTIALLY HLA-MATCHED EPSTEIN BARR VIRUS-SPECIFIC CYTOTOXIC T CELLS1

2. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

3. Reconstitution of the latent T-lymphocyte response to Epstein-Barr virus is coincident with long-term recovery from posttransplant lymphoma after adoptive immunotherapy

4. Characterization of Latent Membrane Protein 2 Specificity in CTL Lines from Patients with EBV-Positive Nasopharyngeal Carcinoma and Lymphoma

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapeutic approaches for the treatment of childhood, adolescent and young adult non-Hodgkin lymphoma;British Journal of Haematology;2016-04-07

2. Adoptive therapy for EBV-induced cancers: driving success with post-transplant lymphoproliferative disorder to other EBV-derived tumors;Immunotherapy;2015-06

3. Phase I trial of adoptively transferred tumor-infiltrating lymphocyte immunotherapy following concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma;OncoImmunology;2015-02

4. Cytotoxic T Cell Adoptive Immunotherapy as a Treatment for Nasopharyngeal Carcinoma;Clinical and Vaccine Immunology;2013-12-18

5. Nasopharyngeal Carcinoma Immunotherapy: Current Strategies and Perspectives;Advances in Experimental Medicine and Biology;2013